At a glance
- Notice of Funding Opportunity (NOFO) number: CDC-RFA-PS-24-0047
- Application Due Date: April 29, 2024, 11:59 pm ET
- Letter of Intent Due Date: February 23, 2024
- Contact: nofoinfo@cdc.gov
Funding overview
CDC announces the availability of fiscal year 2024 funds for a cooperative agreement for health departments to implement high-impact HIV prevention and surveillance programs. The purpose of this notice of funding opportunity (NOFO) is to implement a comprehensive HIV prevention and surveillance program to prevent new HIV infections and improve the health of people with HIV. The NOFO aligns with CDC's Division of HIV Prevention (DHP) strategic focus areas to bolster:
- Community engagement.
- Health equity.
- Syndemic and whole-person approaches to HIV prevention.
To access the NOFO:
- Go to Grants.gov.
- Click on the "Search Grants" tab.
- Enter "CDC-RFA-PS-24-0047" into the "Basic Search Criteria-Opportunity Announcement.
- Select "Archived" as the "Opportunity Status".
- Click "Search".
Funding tables and resource distribution
Access the following document for anticipated funding ranges for budget period 1 and subsequent budget periods:
Funding Tables for Core HIV Prevention and Surveillance and Ending the HIV Epidemic (EHE)
The following document contains a list of counties for funding distribution:
Counties per state representing 30% or greater HIV diagnosis in 2021
Eligibility information
The funding opportunity is for eligible health departments for core prevention and surveillance funding. There are approximately 32 additional awards for eligible health departments that represent the 57 jurisdictions included in the U.S. Ending the HIV Epidemic initiative. These jurisdictions include:
- 48 counties.
- 7 states.
- District of Columbia (DC).
- San Juan, Puerto Rico.
Letter of intent
CDC strongly urges you to complete a letter of intent (LOI) prior to submitting your application. The purpose of this letter is to inform CDC of your interest in applying for funding under PS24-0047. Although a LOI is not required and non-binding, it is highly recommended. A LOI allows CDC program staff to estimate the number of and plan for the review of submitted applications.
A completed LOI must be electronically submitted to nofoinfo@cdc.gov.
An email acknowledging CDC's receipt of a LOI submission will be sent to the potential applicant.
Application
Application submission
The application must include complete, stand-alone sections (e.g. project abstract, narrative, budget and budget justification). Each section represent a requested funding program (core and demonstration project). This ensures that each request for a funding program is easily identified and provided to the respective review panel. Each detailed budget and narrative justification should support the activities for the first year of funding. Additionally, it should support a summary narrative for the entire project period.
Application review information
Applications will be reviewed for completeness. Incomplete applications and applications that are non-responsive to the eligibility criteria will not advance through the review process. Applicants will be notified if the application did not meet submission requirements. All eligible and technically acceptable applications will be funded for the core HIV program. For demonstration projects, all applications deemed eligible and technically acceptable by the review panel will be funded in order of:
- Score and rank.
- Availability of funds.
- Geographic diversity.
- Relevance to DHP program priorities.
Notice of award (NoA)
Successful applicants will receive a Notice of Award (NoA) from the CDC Office of Grants Services (OGS). The NoA shall be the only binding, authorizing document between the recipient and CDC. The NoA will be:
- Signed by an authorized Grants Management Officer
- Emailed to the principle investigator (PI)
- Mailed (as a hard copy) to the recipient fiscal officer identified in the application
Any application awarded in response to this NOFO will be subject to the following requirements:
- DUNS.
- CCR Registration.
- Transparency Act.
Frequently asked questions
Read the following Frequently Asked Questions (FAQ) document with questions received from potential applicants:
Contacts
Programmatic technical assistance
Erica K. Dunbar, Senior Advisor for Program
Department of Health and Human Services
Centers for Disease Control and Prevention
1600 Clifton Rd., N.E.
Atlanta, GA 30333
Email: nofoinfo@cdc.gov
Financial, awards management, and budget assistance
Edna Green, Grants Management Specialist
Department of Health and Human Services
Office of Grants Services
Atlanta, GA 30341
Email: ecg4@cdc.gov
Submission difficulties
For assistance with submission difficulties related to Grants.gov, contact the Contact Center by phone at 1-800-518-4726. Hours of operation are 24 hours a day, 7 days a week, except on federal holidays.
All other submission questions
Technical Information Management Section
Department of Health and Human Services
CDC Office of Financial Resources
Office of Grants Services
2920 Brandywine Rd., MS E-14
Atlanta, GA 30341
Telephone: 770-488-2700
Email: ogstims@cdc.gov
CDC Telecommunications for persons with hearing loss is available at: TTY 1-888-232-6348.
Attachments and information resources
Below is the list of Program Guidance and/or related links referenced in the NOFO.
Cluster detection and response
HIV Cluster Detection and Response Guidance for Health Departments
Community engagement
Principles of Community Engagement (Second Edition) (cdc.gov)
Content review guidelines
- Program Guidance on the Review of HIV-related Educational and Information Materials for CDC Assistance Programs, updated June 2016
- Assurance of Compliance Form for the Program Guidance on the Review of HIV-related Educational and Information Materials for CDC Assistance Programs, updated June 2016
Data-to-Care (D2C)
- Data to Care | Treat | Effective Interventions | HIV/AIDS | CDC
- Data-to-Care Program Guidance
- Data-to-Care Reporting Guidance
Data security and confidentiality guidance
- Data Security and Confidentiality Guidelines for HIV, Viral Hepatitis, Sexually Transmitted Disease, and Tuberculosis Programs, 2011
- Certification of compliance with the CDC Data Security and Confidentiality Guidelines and Designation of Overall Responsible Party (ORP) Assurance of Confidentiality Statement
Epidemiologic profile guidance
High-impact prevention (HIP)
High Impact HIV Prevention CDC's Approach to Reducing HIV Infections in the United States
HIV Planning Group (HPG) – Plans and processes
- HIV Planning Guidance, 2012
- Integrated HIV Prevention and Care Plan Guidance, including the Statewide Coordinated Statement of Need, CY 2017- 2021
- EHE Planning Guidance, 2019
HIV surveillance
HIV testing
- Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings, 2006
- Implementing HIV Testing in Nonclinical Settings – A Guide for HIV Testing Providers, 2016
Laboratory testing guidance
Laboratory testing for the diagnosis of HIV infection: updated recommendations, 2014
Partner services
Perinatal HIV prevention program guidance
PrEP guidance
- CDC PrEP Ancillary Support Services Program Guidance for Health Departments (Revised December 2021)
- CDC PrEP Program Guidance for HIV Prevention Health Department Grantees (Revised August 2012) (link retired)
- Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2021 Clinical Practice Guideline
- Updated Guidelines for Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV—United States, 2016
Prevention with Positives (PwP) guidelines
Recommendations for HIV prevention with adults and adolescents with HIV in the United States, 2014
Social determinants of health (SDOH)
- The U.S. Playbook to Address Social Determinants of Health – SDOH-Playbook-3.pdf (whitehouse.gov)
- HHS Call to Action: Addressing Health-Related Social Needs in Communities Across the Nation (hhs.gov) – Call to Action: Addressing Health-Related Social Needs in Communities Across the Nation (hhs.gov)